Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001476

Pres. Research & Development bought 2,531 shares at $1.93 ($4,885)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-06-30 Purchase +2,531 $1.93 $4,885 21,729 D
Open-market purchases · 2,531 sh · avg $1.93 · $4,885
Loading xslF345X06/form4.xml…